Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112757 · ClinicalTrials.gov registry record · NA
Effective Conversion of Individuals at Risk
A NA study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- Terminated
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT05112757: Clinical Trial NA study, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
NCT05112757 is a NA study that was terminated before completion, run by Philips Electronics Nederland B.V. acting through Philips CTO organization. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05112757, a NA study, was terminated before completion, sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization.
- TERMINATED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these symptoms (if any) and inform the participants on their possible diagnosis
Primary Outcome
Number of patients that visited the Primary Care Physician
Interventions
- OTHER Smartphone application use
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2022-02-24 |
| Est. Completion | 2022-12-08 |
| Phase | NA |
Why NCT05112757 stopped before completion
NCT05112757 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Smartphone application use is the first listed.
NCT05112757 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05112757 about?
NCT05112757 is a clinical study titled "Effective Conversion of Individuals at Risk". This study aims to guide participants in recognizing their OSA (obstructive sleep apnea) and AFib (atrial fibrillation) symptoms, realizing what medical conditions can cause these symptoms (if any) and inform the participants on their possible diagnosis
What is the current status of trial NCT05112757?
This trial is currently terminated. It is a NA study. The enrollment target is 77 participants. The study started on 2022-02-24. Estimated completion is 2022-12-08.
What interventions are being tested in trial NCT05112757?
The interventions under investigation include: Smartphone application use (OTHER).
Who is sponsoring clinical trial NCT05112757?
This trial is sponsored by Philips Electronics Nederland B.V. acting through Philips CTO organization, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05112757's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI